SCHEMBL27486759

SCHEMBL27486759

COC(=O)Cc1ccc2c(C(=O)c3ccccc3)cn(Cc3ccccc3)c2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.56
▸ ALDH1A1 P00352 2/20 0.56
▸ HDAC1 Q13547 3/20 0.56
▸ HDAC2 Q92769 3/20 0.56
▸ HDAC6 Q9UBN7 3/20 0.56
▸ TP53 P04637 4/20 0.55
▸ MAPT P10636 4/20 0.55
▸ HPGD P15428 1/20 0.51
▸ TSHR P16473 1/20 0.51
▸ ADORA1 P30542 1/20 0.49
▸ HDAC3 O15379 1/20 0.48
▸ HDAC4 P56524 1/20 0.48
▸ HDAC7 Q8WUI4 1/20 0.48
▸ HDAC10 Q969S8 1/20 0.48
▸ HDAC11 Q96DB2 1/20 0.48
▸ HDAC8 Q9BY41 1/20 0.48
▸ HDAC9 Q9UKV0 1/20 0.48
▸ HDAC5 Q9UQL6 1/20 0.48
▸ SERPINE1 P05121 1/20 0.48
▸ POLB P06746 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27555299 0.89 POLB (0.55) LMNAALDH1A1HDAC1HDAC2HDAC6
SCHEMBL8390400 0.87 ADORA1 (0.54) LMNAALDH1A1HDAC1HDAC2HDAC6
SCHEMBL27522647 0.81 MAPT (0.52) LMNAALDH1A1MAPTHPGDTSHR
SCHEMBL8802855 0.80 LMNA (0.64) LMNAALDH1A1HDAC1HDAC2HDAC6
SCHEMBL27486760 0.79 LMNA (0.61) LMNAALDH1A1HDAC1HDAC2HDAC6
SCHEMBL8388127 0.76 POLB (0.60) ALDH1A1HPGDADORA1SERPINE1POLB
SCHEMBL2438014 0.75 ITGB1 (0.51) HDAC1HDAC6MAPTHPGDTSHR
SCHEMBL27475773 0.74 HDAC8 (0.62) HDAC1HDAC2HDAC6MAPTHPGD
SCHEMBL1562983 0.73 HDAC1 (0.77) LMNAALDH1A1HDAC1HDAC2HDAC6
SCHEMBL11470606 0.73 SRD5A2 (0.50) LMNAALDH1A1MAPTHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1166169-A Heterocyclic compounds, useful as allosteric effectors at muscarinic receptors SANKYO CO (JP) 1997-11-26 — — CN disclosed
Send feedback